Invention Grant
- Patent Title: Opioid agonist formulations with releasable and sequestered antagonist
-
Application No.: US14333584Application Date: 2014-07-17
-
Publication No.: US09949930B2Publication Date: 2018-04-24
- Inventor: Christopher Breder , Curtis Wright , Benjamin Oshlack
- Applicant: Purdue Pharma L.P.
- Applicant Address: US CT Stamford
- Assignee: Purdue Pharma L.P.
- Current Assignee: Purdue Pharma L.P.
- Current Assignee Address: US CT Stamford
- Agency: Davidson, Davidson & Kappel, LLC
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/16 ; A61K9/50 ; A61K31/44 ; A61K31/445 ; A61K31/485 ; A61K31/46 ; A61K45/06 ; A61K9/14 ; A61K47/32 ; A61K47/38
Abstract:
Disclosed are oral dosage forms, comprising (i) a therapeutically effective amount of an opioid agonist; (ii) an opioid antagonist in releasable form; and (iii) a sequestered opioid antagonist which is not released when the dosage form is administered intact, and methods thereof.
Public/Granted literature
- US20150110879A1 OPIOID AGONIST FORMULATIONS WITH RELEASABLE AND SEQUESTERED ANTAGONIST Public/Granted day:2015-04-23
Information query
